Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Dr. Reddy's Laboratories, Inc.

Dr. Reddy's Laboratories, Inc. Recalls

All product recalls associated with Dr. Reddy's Laboratories, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 21–23 of 23 recalls

Glimepiride Tablets 1mg (Dr. Reddy's) – Tablet Misprint (2024)

Misprint on tablet

Class IIILow

FDAJan 18, 2024Nationwide• Dr. Reddy's Laboratories, Inc.

Glimepiride Tablets 1mg 500-count (Dr. Reddy's) – Tablet Misprint (2024)

Misprint on tablet

Class IIILow

FDAJan 18, 2024Nationwide• Dr. Reddy's Laboratories, Inc.

Tacrolimus Capsules (Dr. Reddy's) - Incorrect Capsule Mix (2023)

Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.

Class II

Page 2 of 2Next

Moderate

FDAFeb 8, 2023Nationwide• Dr. Reddy's Laboratories, Inc.